CJC-1295 DAC (5mg) Long-Acting GHRH Analog for Growth Hormone and Endocrine Research
CJC-1295 DAC (5mg) is a research peptide designed to extend the biological half-life of growth hormone-releasing hormone (GHRH) analogs through Drug Affinity Complex (DAC) technology. It is widely used in scientific studies focused on sustained growth hormone (GH) secretion, metabolic regulation, and endocrine feedback mechanisms.
Product Overview This 5mg vial of lyophilized CJC-1295 DAC provides researchers with a stable, long-acting GHRH analog that remains active in circulation for extended periods. It supports investigations into GH/IGF-1 axis modulation, pituitary function, and anabolic signaling pathways.
Key Research Attributes:
- DAC-Enhanced Stability: The Drug Affinity Complex extends peptide half-life, allowing for prolonged GH receptor stimulation in experimental models.
- Endocrine and Metabolic Focus: Studied in relation to GH-dependent processes such as protein synthesis, lipolysis, and cellular regeneration.
- Receptor Activation Modeling: Commonly used in in vitro assays exploring pituitary activation and GH receptor signaling dynamics.
- High Research Purity: Manufactured to >99% purity, lyophilized for enhanced shelf life and reliable lab performance.
Applications in Scientific Research
- Growth hormone/IGF-1 axis pathway studies
- Endocrine system feedback loop analysis
- Long-term pituitary stimulation modeling
- Anabolic response and GH receptor binding assays
- Comparative testing with short-acting GHRH analogs
Format and Storage Form: Lyophilized powder Purity: >99% Storage: Store at -20°C in a dry, sealed environment Reconstitution: Reconstitute with bacteriostatic water under sterile lab conditions
Disclaimer: CJC-1295 DAC (5mg) is intended exclusively for scientific research and laboratory use. Not for human or veterinary application. Use must comply with institutional, regional, and national guidelines.
Chemical Makeup
Molecular Formula
- CJC-1295 DAC: C165H271N47O46
Molecular Weight
- CJC-1295 DAC: 3649.9 g/mol
Sequence
- CJC-1295 DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 + DAC
Other Known Titles
- CJC-1295 DAC: CJC-1295 with DAC, Long-acting GHRH analog, Drug Affinity Complex Peptide
CJC-1295 DAC (5mg) is for laboratory use only and not for human consumption. Please consult our Terms and Conditions before ordering.
MORE INFORMATION
| Purity Percentage | 99% Purity |
|---|---|
| Volume | 5MG |
| Bought This Week | 5 |
| New | No |
| Sale | No |
RESEARCH
CJC 1295 with DAC: Effects, Benefits, and Side Effects
CJC 1295 with Drug Affinity Complex is a long acting growth hormone releasing hormone analog studied for its ability to prolong growth hormone elevation through extended half life kinetics. Its DAC component allows for sustained GH signalling, making it a model compound for studying metabolic, endocrine, and regenerative pathways. The research sources below outline proposed benefits, mechanisms of action, and reported safety considerations.
-
“CJC 1295 Side Effects, Complications, and Risk Profile” Discusses adverse events including injection site irritation, fluid retention, and general tolerability findings. Read more
-
“CJC 1295 Peptide Guide – Benefits, Effects, Dosage, Side Effects” Reviews body composition findings, metabolic effects, dosing concepts, and pairing with GHRP compounds. Read more
-
“CJC 1295 Side Effects: What You Need to Know” Summarises dizziness, flushing, temperature shifts, and considerations when combined with other secretagogues. Read more
-
“CJC 1295: Benefits, Dosage, Side Effects & Scientific Research” Overviews mechanisms of action, appetite changes, muscle signalling, and potential endocrine effects. Read more
-
“CJC 1295 with DAC Dosage: A Detailed Guide” Covers half life extension, injection frequency, titration approaches, and observed tolerability. Read more
-
“CJC 1295 With and Without DAC: Complete Guide” Compares mechanisms, clearance rates, GH pulsatility, and potential study use cases for each version. Read more
-
“Guide to CJC 1295: Efficiency and Proper Use” Reviews response timing, lab usage considerations, and pairing strategies with other GH pathway agents. Read more
-
“CJC 1295 Overview, Dosage, and Risks” Outlines risks, reported effects, and considerations around combining with other peptide agents. Read more
-
“Ultimate Guide to CJC 1295 with DAC: Benefits, Dosage & Side Effects” Provides full coverage of mechanisms, potential metabolic effects, side effects, and dosing protocols. Read more
-
“What Is CJC 1295 Peptide and Its Benefits & Side Effects” Summarises benefits, dosage discussions, and known risks associated with DAC extended release versions. Read more




Reviews
There are no reviews yet.